SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-22-018439
Filing Date
2022-04-06
Accepted
2022-04-06 16:30:34
Documents
6

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea157966-424b3_180life.htm 424B3 2031897
2 GRAPHIC image_001.jpg GRAPHIC 14214
3 GRAPHIC image_002.jpg GRAPHIC 87724
4 GRAPHIC image_003.jpg GRAPHIC 49881
5 GRAPHIC image_004.jpg GRAPHIC 23813
6 GRAPHIC image_005.jpg GRAPHIC 117862
  Complete submission text file 0001213900-22-018439.txt   2437792
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-258045 | Film No.: 22810926
SIC: 2834 Pharmaceutical Preparations